Board-certified dermatologist and dermatological surgeon Dennis Gross, M.D.

Dr. Dennis Gross

Board-certified dermatologist and dermatological surgeon Dennis Gross, M.D., founded his practice in 1990 after completing his residency at the New York University Medical Center, where he earned a medical degree with research distinctions.

With a deep interest in skin that is healthy as well as beautiful, Dr. Gross has executed extensive research at prestigious institutes, including Memorial Sloan-Kettering, on melanoma. His research on skin cancer has been published in multiple peer-reviewed journals, including Journal of Experimental Medicine and Journal of Medical Microbiology. Dr. Gross serves the Skin Cancer Foundation and is an active member of the American Cancer Society, as well as the American Academy of Dermatology, the Society for Dermatological Surgery and Oncology, the American Medical Association, and the New York Dermatology Society.

Dr. Gross created his award-winning product line, Dr. Dennis Gross Skincare™, in 2002. He and his skincare expertise have been featured in publications including The New York Times Magazine, Elle, Vogue, and Harper’s Bazaar, inaddition to guest appearances on The Today Show, CNN, and The Early Show.

Board Certified Dermatologist & Dermatologic Surgeon
American Board of Dermatology (1990)
Residency Training Program
New York University Medical Center (1987-1990)
Department of Dermatology/Skin and Cancer Unit
Internal Medicine Internship (1986-1987)
Albert Einstein College of Medicine
Montefiore Medical Center
Board Certified: General Medicine (Part III NBME)
Medical School (1982-1986)
State University of New York at Stony Brook
Research Distinction Award
Lemberg Foundation Grant and Scholarship Award for
Cancer Research by a Medical Student
College Education (1976-1980)
Wesleyan University, Middleton, CT
Major: Biology/Psychology
Magna Cum Laude
High Honors Senior Thesis in Microbiology
High School Education (1972-1976)
The Bronx High School of Science
Lectures and Presentations
“Recipe for Healthier Skin”
All the Anti-Aging Ingredients You Need to Look
Younger Longer
The 92nd Street Y (11/09/2010)
“Our Changing Beauty Environment”
How the Environment Wreaks Havoc on Our Skin
The 92nd Street Y (10/27/09)
“Ozone Depletion: Relevance to
Dermatologic Oncology”
American Cancer Society
New York Dermatologic Society
“Early Detection and Prevention of Skin Cancer”
American Cancer Society, New York Chapter
Morgan Stanley Trust Company
New York University Staff Wellness Program
Metropolitan Life Insurance Company / B’nai Brith
American Telephone and Telegraph (AT&T)

“Current Trends in Melanoma”
American Cancer Society Regional Symposium, 
Binghamton, NY
“Epithelioid Angiomatosis – An AIDS Dermatosis
Caused by the Catscratch Coccobacillus”
American Academy of Dermatology National 
Convention, San Francisco, CA
“Arsenicism and Cutaneous Malignancy”
“Contact Urticaria”
New York University Medical Center Dermatology
CME Evening Conferences

Fluorescent Light and Skin Cancer Risk.
In: Textbook of Exogenous Dermatoses:
Environmental Dermatology. Menne and Maibach,
M.D., Editors. CRC Press.
The Many Faces of Malignant Melanoma.
Primary Care and Cancer, pp. 1613-23.
Prognostic Index for Malignant Melanoma. 
Cancer, 59:1236-41.
Characteristics of Familial Melanoma. J.A.M.A., 1986,
Surface Antigens of Melanoma and Melanocytes:
Specificity of Induction of Ia Antigens by Human
Interferon. Journal of Experimental Medicine,

Changes in the Serum of Mice Infected with Strepto-
coccus Pneumoniae that Stimulate in-Vitro Multiplica-
tion of Virulent but not Avirulent Strains.
Journal of Medical Microbiology,15:163-72.
Effects of Pre-Bleeding on the Primary Immune
Response in Mice. Immunology Letters, 33:299-301.
Ciprofloxacin-Resistent and Methicillin-Resistent
Staphylcocous Aureas Cellulitis. Journal of the 
American Academy of Dermatology.

Dermatologic Research
Induction of Ia Antigen by Gamma Interferon on Mela-
noma and Melanocytes – demonstrated that gamma
interferon induces Ia expression and is implicated in the
cellular immune response to melanoma.
The role of macrophages and their mechanism as im-
mune clearing cells.
Spontaneous mutations in Pneumococcal bacteria
and their role in colony formation.

Prognostic Index for Malignant Melanoma – showed
that prognosis for Stage I melanoma is best predicted
when the mitotic index is considered along with 
Breslow thickness.
Oncogene Expression in Dysplastic Nevi – serologic
determination of ras-oncogene expression on dys-
plastic nevi specimens.
Characteristics of Familial Melanoma – the unique
clinical features of these patients were examined.


Content not found - Post 757.